89bio, Inc. Annual Income Tax Expense (Benefit) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
89bio, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2018 to 2023.
  • 89bio, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $134K.
  • 89bio, Inc. annual Income Tax Expense (Benefit) for 2023 was $3.87M, a 20253% increase from 2022.
  • 89bio, Inc. annual Income Tax Expense (Benefit) for 2022 was $19K.
  • 89bio, Inc. annual Income Tax Expense (Benefit) for 2021 was -$147K, a 149% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.87M +$3.85M +20253% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-01
2022 $19K +$166K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-01
2021 -$147K -$88K -149% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-01
2020 -$59K -$277K -127% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $218K +$190K +679% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $28K Jan 18, 2018 Dec 31, 2018 10-K 2020-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.